Diabetes Breakthrough: New Treatment Eliminates Insulin therapy for 86% of Patients. A new treatment for type 2 diabetes, combining ReCET and semaglutide, has been shown to eliminate insulin therapy for 86% of participants in a study. The innovative approach, which involves deep sedation and a two-week isocaloric liquid diet, has been found to be safe and well-tolerated. The study, which included 14 participants aged 28 to 75 years, found that at the 6- and 12-month follow-up, all patients no longer required insulin therapy. The maximum dose of semaglutide was well-tolerated by 93% of participants. The study's lead author, Dr. Celine Busch, said that ReCET is a safe and feasible procedure that, when combined with semaglutide, can effectively eliminate the need for insulin therapy. Further randomized controlled trials are planned to further validate these findings. Source https://scitechdaily.com/diabetes-breakthrough-new-treatment-eliminates-insulin-for-86-of-patients/